• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠重度高血压患者使用酮色林的最佳剂量。

The optimal dosage of ketanserin for patients with severe hypertension in pregnancy.

作者信息

van Schie Debby L, de Jeu Renate M, Steyn D Wilhelm, Odendaal Hein J, van Geijn Herman P

机构信息

Department of Obstetrics and Gynaecology, VU Medical Center, Amsterdam, The Netherlands.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2002 May 10;102(2):161-6. doi: 10.1016/s0301-2115(01)00611-x.

DOI:10.1016/s0301-2115(01)00611-x
PMID:11950484
Abstract

OBJECTIVE

To establish the optimal dosage of ketanserin in the treatment of severe hypertension in pregnancy.

STUDY DESIGN

A double blind prospective randomised controlled trail, comparing 10 mg ketanserin given as intravenous boluses either every 10 or 20 min, until the therapeutic goal of 90 mmHg (diastolic blood pressure) was reached, to a maximum of eight boluses. Main outcome measures were treatment failures and caesarean sections for fetal distress.

RESULTS

There was no difference in reaching the therapeutic goal between patients receiving 10 mg ketanserin either every 10 or 20 min.

CONCLUSION

Ketanserin appears to be an attractive medicine in the treatment of severe hypertension in pregnancy, but the optimal dosage could not be established.

摘要

目的

确定酮色林治疗妊娠重度高血压的最佳剂量。

研究设计

一项双盲前瞻性随机对照试验,将每10分钟或20分钟静脉推注10毫克酮色林直至达到舒张压90毫米汞柱的治疗目标(最多推注8次)与对照组进行比较。主要观察指标为治疗失败情况及因胎儿窘迫行剖宫产的情况。

结果

每10分钟或20分钟接受10毫克酮色林治疗的患者在达到治疗目标方面无差异。

结论

酮色林似乎是治疗妊娠重度高血压的一种有吸引力的药物,但无法确定最佳剂量。

相似文献

1
The optimal dosage of ketanserin for patients with severe hypertension in pregnancy.妊娠重度高血压患者使用酮色林的最佳剂量。
Eur J Obstet Gynecol Reprod Biol. 2002 May 10;102(2):161-6. doi: 10.1016/s0301-2115(01)00611-x.
2
Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results.
Eur J Obstet Gynecol Reprod Biol. 1997 Dec;75(2):155-9. doi: 10.1016/s0301-2115(97)00123-1.
3
Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia.酮色林与阿司匹林预防子痫前期的随机对照试验。
Lancet. 1997 Nov 1;350(9087):1267-71. doi: 10.1016/s0140-6736(97)06408-8.
4
Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial.酮色林与双肼屈嗪治疗早发型子痫前期重度高血压的双盲随机对照试验
Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:106-11. doi: 10.1016/j.ejogrb.2015.02.002. Epub 2015 Mar 10.
5
Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial.酮色林与肼苯哒嗪治疗妊娠期高血压——一项随机双盲试验
S Afr Med J. 1995 Jun;85(6):525-8.
6
Population pharmacokinetics of ketanserin in pre-eclamptic patients and its association with antihypertensive response.
Fundam Clin Pharmacol. 2005 Oct;19(5):585-90. doi: 10.1111/j.1472-8206.2005.00354.x.
7
Blood pressure patterns in pregnant patients on oral ketanserin.
Cardiovasc J S Afr. 2001 Apr-May;12(2):82-7.
8
Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist.新型5-羟色胺受体拮抗剂酮色林对先兆子痫性高血压的控制作用
Am J Obstet Gynecol. 1984 Jul 1;149(5):496-500. doi: 10.1016/0002-9378(84)90023-1.
9
Insufficient efficacy of intravenous ketanserin in severe early-onset pre-eclampsia.静脉注射酮色林治疗重度早发型子痫前期疗效不足。
Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):199-203. doi: 10.1016/j.ejogrb.2005.11.032. Epub 2006 Jan 4.
10
Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin.
Obstet Gynecol Surv. 2000 Sep;55(9):582-9. doi: 10.1097/00006254-200009000-00024.

引用本文的文献

1
Bioactive secondary metabolites from acid mine waste extremophiles.来自酸性矿山废弃物嗜极微生物的生物活性次生代谢产物。
Nat Prod Commun. 2014 Jul;9(7):1037-44.
2
Drugs for treatment of very high blood pressure during pregnancy.用于治疗孕期极高血压的药物。
Cochrane Database Syst Rev. 2013 Jul 31;2013(7):CD001449. doi: 10.1002/14651858.CD001449.pub3.
3
Serotonin and blood pressure regulation.血清素与血压调节。
Pharmacol Rev. 2012 Apr;64(2):359-88. doi: 10.1124/pr.111.004697. Epub 2012 Mar 8.
4
5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.5-羟色胺受体与系统性高血压:动脉焦点
Cardiovasc Ther. 2011 Feb;29(1):54-67. doi: 10.1111/j.1755-5922.2010.00173.x.
5
The 5-HT2 antagonist ketanserin is an open channel blocker of human cardiac ether-à-go-go-related gene (hERG) potassium channels.5-羟色胺2(5-HT2)拮抗剂酮色林是人类心脏去甲肾上腺素能相关基因(hERG)钾通道的一种开放通道阻滞剂。
Br J Pharmacol. 2008 Oct;155(3):365-73. doi: 10.1038/bjp.2008.261. Epub 2008 Jun 23.